Delivery Order SPE2DB24D2100-SPE2DB25FBBNX

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $17,025.98 and a completion date of September 22, 2023. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,432.23, is for the provision of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The delivery order has a completion date of June 6, 2024 and a firm fixed price pricing structure. The contract was not set aside for any specific...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,135.44 contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of November 23, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price of $7,719.44 and a completion date of May 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,190.24, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract is a Firm Fixed Price (FFP) Delivery Order, with a completion date of November 29, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 200-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a firm fixed-price of $1,668.96 and a completion date of July 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,204.87 firm fixed price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 28, 2023 and was awarded on March 27, 2023. This delivery order is part of a larger $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,364.05, is for the provision of Trelegy Ellipta 100-62.5-25 60s, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract is a firm fixed-price delivery order, with a completion date of May 29, 2024. The contract was not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60s, a medication used in the treatment of chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $1,364.02 and is a firm fixed-price delivery order with a period of performance through July 17, 2024. This contract is not set aside for any specific business type....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $14,061.15 and is for the supply of Trelegy Ellipta 200-62.5-25 60S, a prescription medication. The contract has an ultimate completion date of August 30, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBBNX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has a total ceiling value of $2,503.80 and an ultimate completion date of January 7, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/7/25, 10:45 AM